Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update).
diabetic foot
diagnosis
foot ulcer
guidelines
peripheral artery disease
prognosis
surgery
vascular disease
Journal
Diabetes/metabolism research and reviews
ISSN: 1520-7560
Titre abrégé: Diabetes Metab Res Rev
Pays: England
ID NLM: 100883450
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
01
02
2019
revised:
01
05
2019
accepted:
20
05
2019
pubmed:
21
1
2020
medline:
23
1
2021
entrez:
21
1
2020
Statut:
ppublish
Résumé
The International Working Group on the Diabetic Foot (IWGDF) has published evidence-based guidelines on the prevention and management of diabetic foot disease since 1999. This guideline is on the diagnosis, prognosis, and management of peripheral artery disease (PAD) in patients with foot ulcers and diabetes and updates the previous IWGDF Guideline. Up to 50% of patients with diabetes and foot ulceration have concurrent PAD, which confers a significantly elevated risk of adverse limb events and cardiovascular disease. We know that the diagnosis, prognosis, and treatment of these patients are markedly different to patients with diabetes who do not have PAD and yet there are few good quality studies addressing this important subset of patients. We followed the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology to devise clinical questions and critically important outcomes in the patient-intervention-comparison-outcome (PICO) format, to conduct a systematic review of the medical-scientific literature, and to write recommendations and their rationale. The recommendations are based on the quality of evidence found in the systematic review, expert opinion where evidence was not available, and a weighing of the benefits and harms, patient preferences, feasibility and applicability, and costs related to the intervention. We here present the updated 2019 guidelines on diagnosis, prognosis, and management of PAD in patients with a foot ulcer and diabetes, and we suggest some key future topics of particular research interest.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e3276Informations de copyright
© 2020 John Wiley & Sons Ltd.
Références
Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49(2):106-116. https://doi.org/10.1080/07853890.2016.1231932.
Narres M, Kvitkina T, Claessen H, Droste S, Schuster B, Morbach S, Rümenapf G, van Acker K, Icks A. Incidence of lower extremity amputations in the diabetic compared with the non-diabetic population: a systematic review. Grabowski A, ed. PLoS One. 2017;12(8):e0182081. doi:https://doi.org/10.1371/journal.pone.0182081.
Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 2007;50(1):18-25. https://doi.org/10.1007/s00125-006-0491-1.
Morbach S, Furchert H, Groeblinghoff U, et al. Long-term prognosis of diabetic foot patients and their limbs. Diabetes Care. 2012;35(10):2021-2027. https://doi.org/10.2337/dc12-0200.
Rigato M, Pizzol D, Tiago A, Putoto G, Avogaro A, Fadini GP. Characteristics, prevalence, and outcomes of diabetic foot ulcers in Africa. A systemic review and meta-analysis. Diabetes Res Clin Pract. 2018;142:63-73. https://doi.org/10.1016/j.diabres.2018.05.016.
Younis BB, Shahid A, Arshad R, Khurshid S, Ahmad M, Yousaf H. Frequency of foot ulcers in people with type 2 diabetes, presenting to specialist diabetes clinic at a Tertiary Care Hospital, Lahore, Pakistan. BMC Endocr Disord. 2018;18(1):53. https://doi.org/10.1186/s12902-018-0282-y.
Dolan NC, Liu K, Criqui MH, et al. Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care. 2002;25(1):113-120.
Boyko EJ, Ahroni JH, Davignon D, Stensel V, Prigeon RL, Smith DG. Diagnostic utility of the history and physical examination for peripheral vascular disease among patients with diabetes mellitus. J Clin Epidemiol. 1997;50(6):659-668. https://doi.org/10.1016/S0895-4356(97)00005-X.
Edmonds ME, Morrison N, Laws JW, Watkins PJ. Medial arterial calcification and diabetic neuropathy. BMJ. 1982;284(6320):928-930.
Elgzyri T, Larsson J, Thörne J, Eriksson K-F, Apelqvist J. Outcome of ischemic foot ulcer in diabetic patients who had no invasive vascular intervention. Eur J Vasc Endovasc Surg. 2013;46(1):110-117. https://doi.org/10.1016/j.ejvs.2013.04.013.
Spreen MI, Gremmels H, Teraa M, et al. Diabetes is associated with decreased limb survival in patients with critical limb ischemia: pooled data from two randomized controlled trials. Diabetes Care. 2016;39(11):2058-2064. https://doi.org/10.2337/dc16-0850.
Richter L, Freisinger E, Lueders F, Gebauer K, Meyborg M, Malyar NM. Impact of diabetes type on treatment and outcome of patients with peripheral artery disease. Diab Vasc Dis Res. 2018;15(6):504-510. https://doi.org/10.1177/1479164118793986.
Blinc A, Kozak M, Šabovič M, et al. Survival and event-free survival of patients with peripheral artery disease undergoing prevention of cardiovascular disease. Int Angiol. 2017;36(3):216-227. https://doi.org/10.23736/S0392-9590.16.03731-7.
Lipsky BA, Senneville E, Abbas ZG, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(S1):e3280.
Junrungsee S, Kosachunhanun N, Wongthanee A, Rerkasem K. History of foot ulcers increases mortality among patients with diabetes in Northern Thailand. Diabet Med. 2011;28(5):608-611. https://doi.org/10.1111/j.1464-5491.2011.03262.x.
Jeffcoate WJ, Bus SA, Game FL, et al. Reporting standards of studies and papers on the prevention and management of foot ulcers in diabetes: required details and markers of good quality. Lancet Diabetes Endocrinol. 2016;4(9):781-788. https://doi.org/10.1016/S2213-8587(16)30012-2.
Hinchliffe RJ, Brownrigg JRW, Apelqvist J, et al. IWGDF guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes. Diabetes Metab Res Rev. 2015;32(Suppl 1):n/a-n/a. https://doi.org/10.1002/dmrr.2698.
Alonso-Coello P, Oxman AD, Moberg J, et al. GRADE evidence to decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: clinical practice guidelines. BMJ. 2016;353:i2089. https://doi.org/10.1136/bmj.i2089.
Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926. https://doi.org/10.1136/bmj.39489.470347.AD.
Forsythe RO, Apelqvist J, Boyko EJ, et al. Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: A systematic review. Diabetes Metab Res Rev. 2020;36(S1):e3277.
Forsythe RO, Apelqvist J, Boyko EJ, et al. Performance of prognostic markers in the prediction of wound healing or amputation among patients with foot ulcers in diabetes: A systematic review. Diabetes Metab Res Rev. 2020;36(S1):e3278.
Forsythe RO, Apelqvist J, Boyko EJ, et al. Effectiveness of revascularisation of the ulcerated foot in patients with diabetes and peripheral artery disease: A systematic review. Diabetes Metab Res Rev. 2020;36(S1):e3279.
Bus SA, van Netten JJ, Apelqvist J, Lipsky BA, Schaper NC, IWGDF Editorial Board. Standards for the development and methodology of the 2019 International Working Group on the Diabetic Foot guidelines. Diabetes Metab Res Rev. 2020;36(S1):e3267.
Hingorani A, LaMuraglia GM, Henke P, et al. The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. YMVA. 2016;63(2):3S-21S. https://doi.org/10.1016/j.jvs.2015.10.003.
Hart T, Milner R, Cifu A. Management of a diabetic foot. JAMA. 2017;318(14):1387-1388. https://doi.org/10.1001/jama.2017.11700.
National Institute for Health and Clinical Excellence, NICE Guidelines [CG119] Diabetic Foot Problems. 2011.
McGee SR, Boyko EJ. Physical examination and chronic lower-extremity ischemia: a critical review. Arch Intern Med. 1998;158(12):1357-1364.
Soares MM, Boyko EJ, Ribeiro J, Ribeiro I, Ribeiro MD. Predictive factors for diabetic foot ulceration: a systematic review. Diabetes Metab Res Rev. 2012;28(7):574-600. https://doi.org/10.1002/dmrr.2319.
Norgren L, Hiatt WR, Dormandy JA. Inter-society consensus for the management of peripheral artery disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(1):S1-S75.
Rayman G, Hassan A, Tooke JE. Blood-flow in the skin of the foot related to posture in diabetes-mellitus. BMJ. 1986;292(6513):87-90.
Collins TC, Suarez-Almazor M, Peterson NJ. An absent pulse is not sensitive for the early detection of peripheral artery disease. Fam Med. 2006;38(1):38-42.
Andros G, Harris RW, Dulawa LB, Oblath RW, Sallescunha SX. The need for arteriography in diabetic-patients with gangrene and palpable foot pulses. Arch Surg. 1984;119(11):1260-1263.
Chantelau E, Lee KM, Jungblut R. Association of below-knee atherosclerosis to medial arterial calcification in diabetes-mellitus. Diabetes Res Clin Pract. 1995;29(3):169-172.
Randhawa MS, Reed GW, Grafmiller K, Gornik HL, Shishehbor MH. Prevalence of tibial artery and pedal arch patency by angiography in patients with critical limb ischemia and noncompressible ankle brachial index. Circ Cardiovasc Interv. 2017;10(5):e004605. https://doi.org/10.1161/CIRCINTERVENTIONS.116.004605.
Wukich DK, Shen W, Raspovic KM, Suder NC, Baril DT, Avgerinos E. Noninvasive arterial testing in patients with diabetes: a guide for foot and ankle surgeons. Foot Ankle Int. 2015;36(12):1391-1399. https://doi.org/10.1177/1071100715593888.
Vriens B, D'Abate F, Ozdemir BA, et al. Clinical examination and non-invasive screening tests in the diagnosis of peripheral artery disease in people with diabetes-related foot ulceration. Diabet Med. 2018;35(7):895-902. https://doi.org/10.1111/dme.13634.
Tehan PE, Barwick AL, Sebastian M, Chuter VH. Diagnostic accuracy of resting systolic toe pressure for diagnosis of peripheral artery disease in people with and without diabetes: a cross-sectional retrospective case-control study. J Foot Ankle Res. 2017;10(1). https://doi.org/10.1186/s13047-017-0236-z.
Barshes NR, Flores E, Belkin M, Kougias P, Armstrong DG, Mills JLS. The accuracy and cost-effectiveness of strategies used to identify peripheral artery disease among patients with diabetic foot ulcers. YMVA. 2016;64(6):1682. https://doi.org/10.1016/j.jvs.2016.04.056.
Bunte MC, Jacob J, Nudelman B, Shishehbor MH. Validation of the relationship between ankle-brachial and toe-brachial indices and infragenicular arterial patency in critical limb ischemia. Vasc Med. 2015;20(1):23-29. https://doi.org/10.1177/1358863X14565372.
Wang Z, Hasan R, Firwana B, et al. A systematic review and meta-analysis of tests to predict wound healing in diabetic foot. YMVA. 2016;63(2):29S-U99. https://doi.org/10.1016/j.jvs.2015.10.004.
Ince P, Game FL, Jeffcoate WJ. Rate of healing of neuropathic ulcers of the foot in diabetes and its relationship to ulcer duration and ulcer area. Diabetes Care. 2007;30(3):660-663. https://doi.org/10.2337/dc06-2043.
Schreuder SM, Nieuwdorp M, Koelemay MJW, Bipat S, Reekers JA. Testing the sympathetic nervous system of the foot has a high predictive value for early amputation in patients with diabetes with a neuroischemic ulcer. BMJ Open Diabetes Res Care. 2018;6(1):e000592. https://doi.org/10.1136/bmjdrc-2018-000592.
Elgzyri T, Larsson J, Nyberg P, Thörne J, Eriksson K-F, Apelqvist J. Early revascularization after admittance to a diabetic foot center affects the healing probability of ischemic foot ulcer in patients with diabetes. Eur J Vasc Endovasc Surg. 2014;48(4):440-446. https://doi.org/10.1016/j.ejvs.2014.06.041.
Noronen K, Saarinen E, Alback A, Venermo M. Analysis of the elective treatment process for critical limb lschaemia with tissue loss: diabetic patients require rapid revascularisation. Eur J Vasc Endovasc Surg. 2017;53(2):206-213. https://doi.org/10.1016/j.ejvs.2016.10.023.
Sheehan P, Jones P, Caselli A, Giurini JM, Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care. 2003;26(6):1879-1882. https://doi.org/10.2337/diacare.26.6.1879.
Gershater MA, Londahl M, Nyberg P, et al. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia. 2009;52(3):398-407. https://doi.org/10.1007/s00125-008-1226-2.
Monteiro-Soares M, Russell D, Boyko EJ, et al. Guidelines on the classification of diabetic foot ulcers (IWGDF 2019). Diabetes Metab Res Rev. 2020;36(S1):e3273.
Mills JL, Conte MS, Armstrong DG, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014;59(1):220-34.e1-2. https://doi.org/10.1016/j.jvs.2013.08.003.
Alliance STSALS. https://diabeticfootonline.com/2015/09/15/download-the-wifi-threatened-limb-score-theres-an-app-for-that/.
Schaper NC, Andros G, Apelqvist J, Bakker K, Lammer J, Lepäntalo M, Mills JL, Reekers J, Shearman CP, Zierler RE, Hinchliffe RJ. Diagnosis and treatment of peripheral artery disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot. Schaper N, Houtum W, Boulton A, eds. Diabetes Metab Res Rev. 2012;28 (S1):218-224. doi:https://doi.org/10.1002/dmrr.2255.
Boyko EJ, Ahroni JH, Stensel VL, Smith DG, Davignon DR, Pecoraro RE. Predictors of transcutaneous oxygen tension in the lower limbs of diabetic subjects. Diabet Med. 1996;13(6):549-554. https://doi.org/10.1002/(SICI)1096-9136(199606)13:6<549::AID-DIA126>3.0.CO;2-R.
Pinzur MS, Stuck R, Sage R, Osterman H. Transcutaneous oxygen-tension in the dysvascular foot with infection. Foot Ankle. 1993;14(5):254-256.
Lehrman ED, Plotnik AN, Hope T, Saloner D. Ferumoxytol-enhanced MRI in the peripheral vasculature. Clin Radiol. 2019;74(1):37-50. https://doi.org/10.1016/j.crad.2018.02.021.
Lepäntalo M, Mätzke S. Outcome of unreconstructed chronic critical leg ischaemia. Eur J Vasc Endovasc Surg. 1996;11(2):153-157. https://doi.org/10.1016/S1078-5884(96)80044-X.
Stimpson AL, Dilaver N, Bosanquet DC, Ambler GK, Twine CP. Angiosome specific revascularisation: does the evidence support it? Eur J Vasc Endovasc Surg. 2018;57:311-317. https://doi.org/10.1016/j.ejvs.2018.07.027.
Jongsma H, Bekken JA, Akkersdijk GP, Hoeks SE, Verhagen HJ, Fioole B. Angiosome-directed revascularization in patients with critical limb ischemia. J Vasc Surg. 2017;65(4):1208-1219.e1. https://doi.org/10.1016/j.jvs.2016.10.100.
Lo ZJ, Lin Z, Pua U, et al. Diabetic foot limb salvage-a series of 809 attempts and predictors for endovascular limb salvage failure. Ann Vasc Surg. 2018;49:9-16. https://doi.org/10.1016/j.avsg.2018.01.061.
Khor BYC, Price P. The comparative efficacy of angiosome-directed and indirect revascularisation strategies to aid healing of chronic foot wounds in patients with co-morbid diabetes mellitus and critical limb ischaemia: a literature review. J Foot Ankle Res. 2017;10(1). https://doi.org/10.1186/s13047-017-0206-5.
Alexandrescu V, Hubermont G. The challenging topic of diabetic foot revascularization: does the angiosome-guided angioplasty may improve outcome. J Cardiovasc Surg (Torino). 2012;53(1):3-12.
Lejay A, Georg Y, Tartaglia E, et al. Long-term outcomes of direct and indirect below-the-knee open revascularization based on the angiosome concept in diabetic patients with critical limb ischemia. Ann Vasc Surg. 2014;28(4):983-989. https://doi.org/10.1016/j.avsg.2013.08.026.
Caselli A, Latini V, Lapenna A, et al. Transcutaneous oxygen tension msonitoring after successful revascularization in diabetic patients with ischaemic foot ulcers. Diabet Med. 2005;22(4):460-465. https://doi.org/10.1111/j.1464-5491.2004.01446.x.
Meecham L, Patel S, Bate GR, Bradbury AW. Editor's choice - a comparison of clinical outcomes between primary bypass and secondary bypass after failed plain balloon angioplasty in the bypass versus angioplasty for severe Ischaemia of the limb (BASIL) trial. Eur J Vasc Endovasc Surg. 2018;55(5):666-671. https://doi.org/10.1016/j.ejvs.2018.02.015.
Bradbury AW, Ruckley CV, Fowkes F, Forbes JF. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366(9501):1925-1934. https://doi.org/10.1016/S0140-6736(05.
Schaper NC, Van Netten JJ, Apelqvist J, Bus SA, Hinchliffe RJ, Lipsky BA, IWGDF Editorial Board. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(S1):e3266.
Prompers L, Schaper N, Apelqvist J, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral artery disease. The EURODIALE study. Diabetologia. 2008;51(5):747-755. https://doi.org/10.1007/s00125-008-0940-0.
Fisher TK, Scimeca CL, Bharara M, Mills JLS, Armstrong DG. A stepwise approach for surgical management of diabetic foot infections. J Am Podiatr Med Assoc. 2010;100(5):401-405. https://doi.org/10.7547/1000401.
Dunning T. Integrating palliative care with usual care of diabetic foot wounds. Diabetes Metab Res Rev. 2016;32(3):303-310. https://doi.org/10.1002/dmrr.2758.
Schreve MA, Vos CG, Vahl AC, et al. Venous arterialisation for salvage of critically ischaemic limbs: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2017;53(3):387-402. https://doi.org/10.1016/j.ejvs.2016.11.007.
Moran PS, Teljeur C, Harrington P, Ryan M. A systematic review of intermittent pneumatic compression for critical limb ischaemia. Vasc Med. 2015;20(1):41-50. https://doi.org/10.1177/1358863X14552096.
Hinchliffe RJ, Brownrigg JRW, Andros G, et al. Effectiveness of revascularisation of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review. Diabetes Metab Res Rev. 2015;32(Suppl 1):136-144. https://doi.org/10.1002/dmrr.2705.
Young MJ, McCardle JE, Randall LE, Barclay JI. Improved survival of diabetic foot ulcer patients 1995-2008: possible impact of aggressive cardiovascular risk management. Diabetes Care. 2008;31(11):2143-2147. https://doi.org/10.2337/dc08-1242.
Anand SS, Bosch J, Eikelboom JW, et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet. 2018;391(10117):219-229. https://doi.org/10.1016/S0140-6736(17)32409-1.
Ali SR, Ozdemir BA, Hinchliffe RJ. Critical appraisal of the quality of evidence addressing the diagnosis, prognosis, and management of peripheral artery disease in patients with diabetic foot ulceration. Eur J Vasc Endovasc Surg. 2018;56(3):401-408. https://doi.org/10.1016/j.ejvs.2018.05.009.
Schaper NC, Kitslaar P. Peripheral vascular disease in diabetes mellitus, chapter 84. In: DeFronzo RA, Ferannini E, Zimmet P, Alberti G, eds. International Textbook of Diabetes Mellitus. Bristol, UK: John Wiley and Sons; 2004:1515-1527.